Merck’s KEYTRUDA receives positive opinion from CHMP

CHMP recommended approval of KEYTRUDA along with fluoropyrimidine- and platinum-containing chemotherapy for locally advanced metastatic HER2-negative gastroesophageal junction adenocarcinoma in adults. Credit: Kwz~commonswiki/commons.wikimedia.org.